Effect of a novel benzimidazole derivative in experimental Schistosoma mansoni infection
- PMID: 24096606
- DOI: 10.1007/s00436-013-3614-x
Effect of a novel benzimidazole derivative in experimental Schistosoma mansoni infection
Abstract
Currently, praziquantel is the only drug of choice for treatment of schistosomiasis. Reports of praziquantel resistance raise concerns about future control of the disease. Therefore, the search for new schistosomicidal drugs is eminent. In this study, the effect of a novel benzimidazole-derived compound (compound BTP-Iso) was assessed in mice harboring adult Schistosoma mansoni (Egyptian strain). Mice were treated 42 days p.i. with compound BTP-Iso using two treatment regimens (200 or 300 mg/kg). In both regimens, there were significant reductions in the number of recovered S. mansoni worms especially females and in immature ova, in addition to a significant reduction in the number and size of hepatic granulomata. A dose of 300 mg/kg resulted in a significant decrease in intestinal and hepatic tissue egg loads. Effect on schistosomes was confirmed by scanning electron microscopy, where adult worms recovered from mice treated with 200 mg/kg of compound BTP-Iso revealed tegumental alternations, characterised by swelling of tegumental ridges, bleb formation, and mild erosion in male worms; however in females, there were extensive erosion and destruction of the tegumental surface. These promising results may encourage future use of compound BTP-Iso in the treatment of schistosomiasis. However, more research is needed to detect the effect of compound BTP-Iso on early developmental stages of S. mansoni and on other species of human schistosomes.
Similar articles
-
Therapeutic efficacy of a newly synthesized benzimidazole compound BTP-OH against murine schistosomiasis mansoni.J Helminthol. 2020 Jul 15;94:e172. doi: 10.1017/S0022149X20000541. J Helminthol. 2020. PMID: 32665046
-
Dose-response relationship in Schistosoma mansoni juvenile and adult stages following limonin treatment in experimentally infected mice.Parasitol Res. 2016 Oct;115(10):4045-54. doi: 10.1007/s00436-016-5177-0. Epub 2016 Jun 20. Parasitol Res. 2016. PMID: 27325399
-
Schistosomicidal and prophylactic activities of phthalimido-thiazoles derivatives on schistosomula and adult worms.Eur J Pharm Sci. 2019 May 15;133:15-27. doi: 10.1016/j.ejps.2019.03.008. Epub 2019 Mar 12. Eur J Pharm Sci. 2019. PMID: 30877068
-
Anthelmintic activity in vitro and in vivo of Baccharis trimera (Less) DC against immature and adult worms of Schistosoma mansoni.Exp Parasitol. 2014 Apr;139:63-72. doi: 10.1016/j.exppara.2014.02.010. Epub 2014 Mar 3. Exp Parasitol. 2014. PMID: 24602876
-
Immune-dependent chemotherapy of schistosomiasis.Parasitology. 1992;105 Suppl:S41-8. doi: 10.1017/s003118200007534x. Parasitology. 1992. PMID: 1308928 Review.
Cited by
-
Present-day anthelmintics and perspectives on future new _targets.Parasitol Res. 2014 Jul;113(7):2425-33. doi: 10.1007/s00436-014-3969-7. Epub 2014 Jun 4. Parasitol Res. 2014. PMID: 24894082 Review.
-
Chemotherapy for human schistosomiasis: how far have we come? What's new? Where do we go from here?RSC Med Chem. 2020 Apr 6;11(4):455-490. doi: 10.1039/d0md00062k. eCollection 2020 Apr 1. RSC Med Chem. 2020. PMID: 33479649 Free PMC article. Review.
-
Repurposing drugs for the treatment and control of helminth infections.Int J Parasitol Drugs Drug Resist. 2014 Jul 30;4(3):185-200. doi: 10.1016/j.ijpddr.2014.07.002. eCollection 2014 Dec. Int J Parasitol Drugs Drug Resist. 2014. PMID: 25516827 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources